Date of publication: May 2024.
Source: St Jude’s Children’s Research Hospital
Scientists at St. Jude Children’s Research Hospital have discovered 156 potential new targets for a type of cancer treatment known as CAR T-cell immunotherapy, which involves reprogramming a patient's immune cells to attack cancer cells.
This breakthrough could enhance treatments for brain and solid tumors. The research, which included testing in mouse models, aims to create more precise therapies that target cancer cells without harming healthy ones. The results of this study have been shared in a public database to encourage further research and development.
